SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A Cross Platform Protocol for Tokenizing Risk.

BarnBridge Token

BarnBridge Token ($BOND) is trending as the community focuses on its limited 10M max supply and potential for a significant price surge. Some speculate about orchestrated buying activity and are setting aggressive sell limits, hoping to trigger a FOMO frenzy. Others are discussing its oversold RSI and whether a price explosion is imminent.

Bounce Token

Bounce Token ($AUCTION) is trending as community members highlight its potential for significant moves and discuss recent price dips as buying opportunities.  Some speculate on factors like AI integration and project utility, while others point to chart patterns and bid activity as bullish signals.  The token's potential to revisit previous highs is also a recurring theme.

Pojak watched as the world played hot potato with CTO shit coins. Now, it's his moment. With Pepe's legendary meme power and Wojak's emotional depth, Pojak brings a new level of influence, wealth, and ethics. Born into meme royalty with luxury and wisdom from Pepe and Wojak, he faced hardship when the original developer rugged the project. The community rose up and took control. Pojak was reborn, stronger and more determined.

Pojak

Pojak ($PJ) is trending amid community discussions about its potential, particularly its association with Phantom Wallet. Some users are highlighting its chart setup and potential for gains, while others are warning of potential scams and past issues. The conversation includes speculation about coordinated pumping and mentions of other cryptocurrencies like $BTC and $SOL.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending amid discussions around recent data from their lung cancer trial and an upcoming presentation at the World Conference on Lung Cancer, with some highlighting positive overall survival trends while others point to regional differences in the data. Community members are debating the significance of the data, potential partnerships, and the company's overall valuation, with strong opinions from both bulls and bears; the influence of insider buying, particularly by Robert Duggan, is also a hot topic.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd.

SU Group Holdings is trending amid discussions about its low float and regained NASDAQ compliance, drawing comparisons to other Hong Kong-based stocks. Traders are also highlighting a recently announced contract and the high cost to borrow, fueling speculation about a potential short squeeze. The company's move into EV infrastructure and AI-powered solutions are also noted by the community.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

Delcath Systems is trending as investors analyze the implications of recent CHOPIN trial data and revenue guidance updates. The community is focused on understanding the potential for Hepzato to become a platform therapy and whether the trial results support earlier application of the treatment, while also debating revenue expectations and the impact of discount programs.

Dogelon Mars

Dogelon Mars is trending amid mixed sentiment, with some traders expressing frustration over its performance and longing for a price surge, while others remain hopeful and are accumulating more tokens. Community discussions revolve around potential catalysts, the metaverse, and skepticism regarding promised 'Great Burns', with some focusing on potential listing on exchanges. Recent discussions center on the broader meme coin market and external factors like tariffs and geopolitical events.

JERRY (JYAI) is a Matt Furie's artistic style; it features an AI-powered content creation hub that produces community-driven video series and art.  Jerry the Turtle, created by Matt Furie, is a character inspired by Furie’s artistic style. JERRY is also an AI-driven meme coin with an ambitious vision. The goal is to establish an AI-powered production house dedicated to creating a video series or episodes featuring characters from Matt Furie’s universe alongside those from Jerry’s world.  This unique blend of characters aims to produce the ultimate crypto-based series. Additionally, we are developing an app that will offer an exclusive, ad-free video series featuring characters from both Matt Furie’s creations and the Jerry Universe. Users will be able to download and share videos directly through the platform.  But that’s not all! A special Jerry Art Panel will showcase original Jerry characters, artwork, and fan creations—free to explore, download, and share with the community.

Jerry The Turtle By Matt Furie

Jerry The Turtle ($JYAI), created by Matt Furie, is gaining attention as community members discuss its potential for significant growth, drawing comparisons to other meme coins like $PEPE. The community is actively anticipating major exchange listings and celebrating its growing number of holders, while highlighting its bridge to BNB.

Synthetix is a decentralized perpetual futures protocol built on Ethereum Mainnet. Synthetix uses a hybrid design — off-chain order matching on a high-performance CLOB with on-chain settlement — to deliver low latency, deep liquidity, and MEV-resistant execution while keeping custody and finality on Ethereum. Traders get CEX-like performance with on-chain security and composability. The protocol’s liquidity is provided by the Synthetix Liquidity Provider (SLP) vault and backstopped by staked SNX collateral, which underwrites the issuance of the sUSD stablecoin and the solvency of the SLP vault.

Synthetix Network 

Synthetix is trending amid community discussion around an upcoming trading competition and major upgrade. Traders are actively discussing potential bullish setups, key support levels, and whether recent price movements are indicative of manipulation. The community is also focused on the project's developments in decentralized perpetual exchanges.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta ($KTA) is trending as the community anticipates the mainnet launch this month, with some speculating on potential partnerships and a Coinbase listing. Discussions highlight Keeta's potential to revolutionize finance and connect blockchains with its anchor technology, while some express concern about sell-the-news events. Many see $KTA as a long-term hold with the potential to disrupt traditional financial systems.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks.com featured highlights include Maximus, Pediatrix Medical, Sally Beauty and State Street

Zacks highlights Maximus, Pediatrix Medical, Sally Beauty, and State Street as stocks trading near 52-week highs with potential for continued upside.

4 Stocks Trading Near 52-Week High With Room to Rise Further

Investors target stocks that have been on a bullish run. Stocks like MMS, MD, SBH and STT are seeing price strength, and the momentum is likely to continue.

Pediatrix Medical Group, Inc. (MD) Soars to 52-Week High, Time to Cash Out?

Pediatrix Medical Group (MD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Down 33.4% YTD, Can Select Medical Stitch Back its Growth Story?

After a 33.4% YTD drop, SEM battles rising costs and weak returns while its rehab unit and valuation keep optimism alive.

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Here's Why Pediatrix Medical Shares Are Attracting Investors Now

MD shares surge on strong earnings, rising revenues, cost cuts and a new $250M buyback plan.

Despite Fast-paced Momentum, Pediatrix Medical Group (MD) Is Still a Bargain Stock

Pediatrix Medical Group (MD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Danaher Gains From Business Strength Amid Persisting Headwinds

DHR posts gains in bioprocessing, biotech and diagnostics, while life sciences softness and high debt weigh.

Zacks.com featured highlights include Post Holdings, Pediatrix Medical, Envista and Zions Bancorporation

Post Holdings, Pediatrix, Envista, and Zions Bancorporation hit 52-week highs as growth, cash flow, and upgrades fuel momentum.

Pediatrix Medical Group, Inc. engages in the provision of physician services. Its services include neonatal care, maternal fetal care, and other pediatric subspeciality care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.

Pediatrix Medical Group Inc

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

MD
MEDNAX Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MD News

MDMEDNAX Inc